Hetero Health Care R & D Centre had developed across a vast area. A striking feature of Hetero Health care is the well-planned and comprehensive infrastructure provided
One of the world leaders in developing and manufacturing a wide range of brands/non-brands generics including oncology and ARV drugs
Basic manufacturer of Oseltamivir (sub-licencing agreement with Hoffmann-La Rosche, Switzerland) Launched biosimilar Rituximab for treatment of chronic leukaemia
When it comes to innovation in the development of new drugs and therapeutic biological products company is completely focused structuring the Molecule need of the industry Innovation Strategy.
We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists .